Financial Performance: Revenue, earnings, and profitability reports directly impact investor confidence.

Industry Trends: Changes in the biotech and pharmaceutical sectors influence investor sentiment towards CLSD.

Clinical Trial Results: Positive or negative data from clinical trials for CLSD's drug candidates significantly affect the stock price.

Regulatory Approvals: FDA approvals or rejections of CLSD's products are critical price drivers.

Competition: The presence and success of competing therapies influence market share expectations.

Market Conditions: Overall stock market performance and investor risk appetite play a role.

Company News: Major announcements about partnerships, acquisitions, or strategic shifts can cause price fluctuations.

Analyst Ratings: Upgrades or downgrades from financial analysts can affect investor perception.

Economic Factors: Economic downturns or upturns can indirectly impact the biotech sector and CLSD's stock.

Management Changes: Changes in leadership or key personnel can create uncertainty or optimism.